Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SPEM family member 2 (SPEM2) is a testis-enriched, 57 kDa protein encoded by the SPEM2 (C17orf74) gene on human chromosome 17p13.1[1][2][3]. SPEM2 is highly conserved across mammals and is predominantly expressed in post-meiotic male germ cells, where it is essential for spermiogenesis and normal sperm maturation[1]. Mouse knockout models lacking Spem2 display male infertility due to multiple spermiogenic defects, including abnormal acrosome formation, excessive cytoplasm retention, reduced sperm motility, and failed sperm-oocyte fusion[1]. SPEM2 localizes to the Golgi apparatus and interacts with proteins critical for acrosome development and sperm function (ZPBP, PRSS21, PRSS54, PRSS55, ADAM2, ADAM3), acting as a scaffold for their processing and maturation[1]. There is no evidence that SPEM2 is a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor. Its clinical relevance may primarily be in male infertility research[1][2][3].
Not a therapeutic target; no drugs act directly on SPEM2
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SPEM family member 2 (SPEM2).